Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac Sodium Gel 1% for Acute Blunt Soft Tissue Injuries
NCT01272947Phase 3Completed
- Sponsor
- Novartis
- Start
- Jan 2011
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of diclofenac sodium in soft tissue injury, sponsored by Novartis. Started Jan 2011; status: completed.
02
Drugs
diclofenac sodium
03
Conditions
soft tissue injury
Beyond the preview
Go deeper on NCT01272947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01272947.